94 related articles for article (PubMed ID: 8677997)
21. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.
Lau GK; Davis GL; Wu SP; Gish RG; Balart LA; Lau JY
Hepatology; 1996 Jun; 23(6):1318-23. PubMed ID: 8675145
[TBL] [Abstract][Full Text] [Related]
22. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment.
Gil B; Qian C; Riezu-Boj JI; Civeira MP; Prieto J
Hepatology; 1993 Nov; 18(5):1050-4. PubMed ID: 8225209
[TBL] [Abstract][Full Text] [Related]
23. alpha-Interferon retreatment of patients with chronic hepatitis C.
Rabinovitz M; Block G; Finkelstein SD
Am J Gastroenterol; 1996 Aug; 91(8):1523-6. PubMed ID: 8759654
[TBL] [Abstract][Full Text] [Related]
24. Changes of hepatic vitronectin levels in patients with chronic hepatitis C treated with interferon alpha.
Yamada S; Suou T; Kawasaki H; Horie Y; Nagami M; Yashima S; Sugihara C; Tanaka H
Res Commun Mol Pathol Pharmacol; 1999; 104(3):253-63. PubMed ID: 10741376
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
26. Hepatic metallothionein in patients with chronic hepatitis C: relationship with severity of liver disease and response to treatment.
Carrera G; Paternain JL; Carrere N; Folch J; Courtade-Saïdi M; Orfila C; Vinel JP; Alric L; Pipy B
Am J Gastroenterol; 2003 May; 98(5):1142-9. PubMed ID: 12809840
[TBL] [Abstract][Full Text] [Related]
27. Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C.
Hofer H; Osterreicher C; Jessner W; Penz M; Steindl-Munda P; Wrba F; Ferenci P
J Hepatol; 2004 Jun; 40(6):1018-22. PubMed ID: 15158344
[TBL] [Abstract][Full Text] [Related]
28. Hepatic alpha-smooth muscle actin expression in hepatitis C patients before and after interferon therapy.
Khan MA; Poulos JE; Brunt EM; Li L; Solomon H; Britton RS; Bacon BR; Di Bisceglie AM
Hepatogastroenterology; 2001; 48(37):212-5. PubMed ID: 11268968
[TBL] [Abstract][Full Text] [Related]
29. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
30. Intrahepatic expression of c-fos, c-myb and c-myc oncogenes: correlation with virus-induced chronic liver disease and response to interferon.
Tappero G; Farina M; Negro F; Anfossi G; Mattiello L; Giuli PD; Colombatto P; Brunetto MR; Angeli A; Bonino F
Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):148-54. PubMed ID: 9646196
[TBL] [Abstract][Full Text] [Related]
31. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron.
Hayashi H; Takikawa T; Nishimura N; Yano M; Isomura T; Sakamoto N
Am J Gastroenterol; 1994 Jul; 89(7):986-8. PubMed ID: 8017395
[TBL] [Abstract][Full Text] [Related]
32. Hepatic iron contents and response to interferon-alpha in patients with chronic hepatitis C. Relationship to genotypes of hepatitis C virus.
Izumi N; Enomoto N; Uchihara M; Murakami T; Ono K; Noguchi O; Miyake S; Nouchi T; Fujisawa K; Marumo F; Sato C
Dig Dis Sci; 1996 May; 41(5):989-94. PubMed ID: 8625774
[TBL] [Abstract][Full Text] [Related]
33. A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C.
Banner BF; Barton AL; Cable EE; Smith L; Bonkovsky HL
Mod Pathol; 1995 Apr; 8(3):232-8. PubMed ID: 7542385
[TBL] [Abstract][Full Text] [Related]
34. Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment.
Boucher E; Bourienne A; Adams P; Turlin B; Brissot P; Deugnier Y
Gut; 1997 Jul; 41(1):115-20. PubMed ID: 9274482
[TBL] [Abstract][Full Text] [Related]
35. Time course of histological changes in patients with a sustained biochemical and virological response to interferon-alpha therapy for chronic hepatitis C virus infection.
Tsubota A; Kumada H; Chayama K; Arase Y; Saitoh S; Koida I; Suzuki Y; Kobayashi M; Murashima N; Ikeda K
J Hepatol; 1997 Jul; 27(1):49-55. PubMed ID: 9252073
[TBL] [Abstract][Full Text] [Related]
36. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy.
Barton AL; Banner BF; Cable EE; Bonkovsky HL
Am J Clin Pathol; 1995 Apr; 103(4):419-24. PubMed ID: 7537017
[TBL] [Abstract][Full Text] [Related]
37. Failure to respond to interferon-alpha 2a therapy is associated with increased hepatic iron levels in patients with chronic hepatitis C.
Kageyama F; Kobayashi Y; Murohisa G; Shimizu E; Suzuki F; Kikuyama M; Souda K; Kawasaki T; Nakamura H
Biol Trace Elem Res; 1998; 64(1-3):185-96. PubMed ID: 9845473
[TBL] [Abstract][Full Text] [Related]
38. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.
Olynyk JK; Reddy KR; Di Bisceglie AM; Jeffers LJ; Parker TI; Radick JL; Schiff ER; Bacon BR
Gastroenterology; 1995 Apr; 108(4):1104-9. PubMed ID: 7698578
[TBL] [Abstract][Full Text] [Related]
39. Hepatic stellate cells in hepatitis C patients: relationship with liver iron deposits and severity of liver disease.
Martinelli AL; Ramalho LN; Zucoloto S
J Gastroenterol Hepatol; 2004 Jan; 19(1):91-8. PubMed ID: 14675249
[TBL] [Abstract][Full Text] [Related]
40. [Long-term prognosis of the interferon-treated patients with chronic hepatitis C].
Yoshida H; Iwabuchi S; Murayama M; Uchikoshi T
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):675-9. PubMed ID: 7563855
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
